Synlogic (SYBX)
(Delayed Data from NSDQ)
$1.83 USD
+0.06 (3.39%)
Updated Apr 18, 2024 03:58 PM ET
After-Market: $1.85 +0.02 (1.09%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Brokerage Reports
Synlogic, Inc. [SYBX]
Reports for Purchase
Showing records 21 - 40 ( 109 total )
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Synthetic Biotic Publication; Cash Replenished; Modulating PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB1618 Proof-of-Concept Data Approaching; 2Q21 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB1934 Next-Generation Phenylketonuria Candidate Enters Clinic; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Roche Collaboration Announced; Solid Balance Sheet; Lowering PT to $9
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage Due to Realignment of Analyst Resources
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
3Q20 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
SYNB8802 Phase 1 Trial Initiated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Updates on Multiple Fronts; 2Q20 Financials Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Collaboration Agreement Terminated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
Company: Synlogic, Inc.
Industry: Medical - Biomedical and Genetics
1Q20 Financials; COVID-19 Trial Slowdown May Persist Near Term; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R